Provision of Drug Abuse Treatment Services Under Parity

描述（由申请人提供）：医疗保健系统的变化使得有必要定期更新我们对如何提供药物使用障碍服务的了解。这在当前环境中尤为重要，因为最近通过了联邦平等立法，要求提供心理健康/成瘾服务的团体健康计划以与医疗/手术服务相当的方式覆盖这些服务，自2010年1月1日起适用于大多数健康计划。在前两轮健康计划调查的基础上，我们建议：（1）通过增加关于药物滥用治疗的具体问题和关于平等的深入模块，加强计划于2010年进行的“核心”第三轮调查;（2）在颁布最终平等条例和完成2011年费用选择退出规定后，于2012年进行一次后续调查，重点关注健康计划的反应。具体目标是： * 通过加强2010年福利调查，特别关注药物滥用服务，并通过与1999年和2003年前几轮调查进行比较，分析过去十年中健康计划提供这些服务的变化，从行政和临床因素的角度描述私人健康计划中提供的药物使用障碍服务。 * 研究保健计划对2010年1月1日实施联邦均等立法的具体反应，通过一个关于均等的特别模块加强2010年的调查，深入分析因均等而具体采取的变革。 * 研究健康计划在2012年福利年对联邦均等立法的进一步反应，此前要求所有在2011年选择退出的计划都参加2012年的计划，并发布了预计将于2011年生效的澄清性最终法规。 * 从2010年到2012年福利年度，保健计划实施均等的模式变化，反映了对均等条例和费用选择退出规定的回应变化。 拟议的药物治疗服务研究将结合联合收割机的1999年，2003年，2010年和2012年的平等后续行动，我们的国家代表性的健康计划调查的前瞻性设计，将使我们能够跟踪如何提供药物服务的不断变化的医疗保健市场。它将特别侧重于与联邦均等有关的问题，特别是根据法规和费用选择退出规定的健康计划反应。

DESCRIPTION (provided by applicant): Changes in the health care system make it necessary to regularly update our knowledge of how services for drug use disorders are provided. It is particularly important in the current environment because of the recent passage of federal parity legislation which requires group health plans offering mental health/addiction services to cover these services in a comparable manner to medical/ surgical services, effective January 1, 2010 for most health plans. Building on two previous rounds of our health plan survey, we propose to (1) enhance the "core" third round planned for 2010 by adding specific questions on drug abuse treatment and an in-depth module on parity, and (2) conduct a follow-up survey in 2012 focused on health plan response after final parity regulations have been issued and the 2011 cost opt-out provision is finished. The specific aims are: * Describe the provision of services for drug use disorders in private health plans in terms of administrative and clinical factors by enhancing a survey for benefit year 2010 to specifically focus on drug abuse services and analyze changes in health plans' provision of these services in the last decade by comparing to previous rounds of the survey in 1999 and 2003. * Study health plans' specific responses to the implementation of federal parity legislation on January 1, 2010 with an in-depth analysis of changes that were specifically adopted because of parity, by enhancing the 2010 survey through a special module on parity. * Study health plans' further responses to federal parity legislation in benefit year 2012, following both the requirement that all plans opting out in 2011 participate in 2012 and the issuance of clarifying final regulations expected to go into effect in 2011. * Model changes from benefit year 2010 to 2012 in health plans' implementation of parity, reflecting changes in response to parity regulations and the cost opt-out provision. The proposed study of drug treatment services will combine the 1999, 2003, and the 2010 rounds and the 2012 parity follow-up of our nationally representative health plan survey in a prospective design that will allow us to track how the delivery of drug services evolves within the changing health care market. It will specifically focus on issues related to federal parity, particularly health plan response in light of regulations and cost opt- out provisions.